News & events

Filter by All categories EventsNews

Press release Flash Therapeutics (EN)
16-05-2018
News
Vectalys & Flashcell merge and create Flash Therapeutics, a new gene therapy company.
Learn more

Vectalys receives the Seal of Excellence from the European Commission
19-01-2018
News
We are proud to announce that Vectalys has been awarded a Seal of Excellence certificate from the European commission as a result of its Horizon 2020 application.  
Learn more

Bioproduction des immunothérapies en France
27-09-2017
News
Pascale Bouillé, CEO of Vectalys and president at FlashCell, was at the "Bioproduction des immunothérapies en France" conference at Biocitech Romainville on 09-26-2017 to talk about our new generat...
Learn more

Upcoming ESGCT 2017 in Berlin
24-09-2017
News
The FlashCell team looks forward to sharing its recent data about LentiFlash™ for genome-editing and immunotherapy approaches at the ESGCT 2017.
Learn more
Launch of FlashCell
01-06-2017
News
Vectalys is proud to launch FlashCell, a new gene therapy company specialized in the development of RNA carriers for therapeutic applications. Learn more about FlashCell company on http://www.flash...
Learn more

ASGCT 2017 in Washington, DC
12-04-2017
News
Vectalys will attend the ASGCT 20th annual meeting in Washington, DC May 10-13, 2017 and will be presenting a poster on efficient KO of PD1 and CXCR4 into primary T cells using LentiFlash.
Learn more

345678